Filters

BCL9 Antibody

BCL9 Antibody size: 0.1ml 263

Price 263
Size 0.1ml
Long nameBCL9 Primary Polyclonal Antibody
Also known asBCL9 PAb
CategoryPrimary Antibodies
ConjugationUnconjugated
Target AntigenBCL9
SpecificityThis is a highly specific antibody against BCL9
Modification(s)None
Modification site(s)Unmodified antibody
ClonalityPolyclonal antibody
Clone numberPolyclonal antibody
Concentration1ug per 1ul
SourceThis antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human BCL9
Gene ID number101060700
Tested Applications IF(IHC-P), IHC-P, WB
Recommended dilutions IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000)
Cross reactivity Mouse, Rat, Human
Cross reactive species details not every possible cross-reactivity is known, Due to limited amount of testing and knowledge
Background of the target antigen Bcl-9L exists as multiple alternatively spliced isoforms and is thought to be involved in tumorigenesis, Bcl-9L functions as a transcriptional activator that forms a complex with Parafibromin and Î, Expressed in breast tissue, Jacobsen syndrome, Jervell and Lange-Nielsen syndrome, Niemann-Pick disease, The gene encoding Bcl-9L maps to human chromosome 11, as well as in eye, hereditary angioedema and Smith-Lemli-Opitz syndrome are associated with defects in genes that maps to chromosome 11, lung, possibly playing a role in tumor transformation and metastasis, prostate and various carcinomas, which houses over 1, ², ², -catenin, -catenin and is thought promote the transcriptional activity of Parafibromin and enhance the neoplastic transforming activity of Î, 400 genes and comprises nearly 4% of the human genome, 499 amino acid protein that localizes to the nucleus and contains a specialized C-terminal domain that is important for its overall activity, Bcl-9L is a 1
Purification methodThis antibody was purified via Protein A
Storage conditions 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA
Synonym names B-cell CLL/lymphoma 9-like, BCL 9, BCL-9, BCL9_HUMAN, DLNB11, LGS, Legless homolog, B-cell CLL/lymphoma 9
PropertiesC, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24°
Gene targetBCL9
Short nameBCL9 Antibody
Technique antibodies against human proteins, antibodies for, Antibody
Alternative nameB-cell CLL/lymphoma 9 (Antibody to)
Alternative techniqueantibodies
Alternative to gene target BCL9 and IDBG-101829 and ENSG00000116128 and 607, BCL9 and IDBG-633778 and ENSBTAG00000002422 and 788729, Bcl9 and IDBG-176803 and ENSMUSG00000038256 and 77578, LGS, beta-catenin binding, nuclei, this GO :0005515 and protein binding and molecular function this GO :0005634 and nucleus and cellular component this GO :0005737 and cytoplasm and cellular component this GO :0005794 and this GO lgi apparatus and cellular component this GO :0005801 and cis- this GO lgi network and cellular component this GO :0008013 and beta-catenin binding and molecular function this GO :0014908 and myotube differentiation involved in skeletal muscle regeneration and biological process this GO :0035019 and somatic stem cell maintenance and biological process this GO :0035914 and skeletal muscle cell differentiation and biological process this GO :0045944 and positive regulation of transcription from RNA polymerase II promoter and biological process this GO :0060070 and canonical Wnt signaling pathway and biological process, this GO :0005515: protein binding, this GO :0005515: protein binding and also this GO :0008013: beta-catenin binding, this GO :0008013: beta-catenin binding, B-cell CLL/lymphoma 9
Identity 1008
Gene BCL9
Long gene name B-cell CLL/lymphoma 9
Locus 1q21, 2
Discovery year 1997-07-01
GenBank acession Y13620
Entrez gene record 607
Pubmed identfication 9490669
RefSeq identity NM_004326
Havana BLAST/BLAT OTTHUMG00000014031

Subscribe to our Newsletter